Resultsbee.com

11600 Wilshire Blvd. Ste 320,Los Angeles,CA

About Steven Rosenblatt, MD Steven Rosenblatt, MD, PhD, LAc, is a physician with his own private medical practice, which has locations in Kamuela, Hawaii, and the Sawtelle neighborhood of West Los Angeles, California. Dr. Rosenblatt was originally trained as an acupuncture and oriental medicine doctor by Dr. Ju Gim Shek. He was taken to Hong Kong, where he graduated from the Hong Kong Acupuncture College as the first Western student of Dr. James Tin Yau So. Upon his return, he organized and was the first clinical director of the UCLA Acupuncture Research Project in the medical school department of anesthesiology.  This was the first acupuncture clinic in a medical school in the United States. Dr. Rosenblatt brought Dr. So to this country where they lived together in Los Angeles before moving east to set up the James-Stevens Acupuncture Center in Boston, Massachusetts. This first training program in the US grew to become the New England School of Acupuncture.  Upon returning to Los Angeles, Dr. Rosenblatt established the California Acupuncture College with branches in Santa Barbara (which later became the Santa Barbara Acupuncture College) and San Diego (which evolved to become the Pacific College of Oriental Medicine). Being actively involved in the political process of creating a licensure program for acupuncture, Dr. Rosenblatt helped create licensing regulations as he spoke and lobbied for legislative action in the states of Nevada, Oregon, and California.  He was the first Westerner licensed to practice acupuncture in the US with license number 8 in the state of Oregon in 1974. Dr. Rosenblatt received his PhD from UCLA with a dissertation entitled Electrophysiological Correlates of Acupuncture Points. This was the first doctoral research dissertation on acupuncture at a major university in the US. As president of the California Acupuncture College, Dr. Rosenblatt helped establish several of the national educational and accreditation agencies.  He served on the National Accreditation Commission for Schools and Colleges of Oriental Medicine for six years and helped review and accredit many of the acupuncture and oriental medicine schools in the US. After 20 years in the acupuncture and oriental medicine field, Dr. Rosenblatt went back to medical school and earned an MD degree from St. Georges University.  He completed his medical school training in England and went on to do a family practice residency at Kaiser Hospital in Riverside, California. Dr. Rosenblatt is National Board Certified in acupuncture and is licensed as a medical doctor in California and Hawaii.  He is residency trained in family practice and is currently board certified in urgent care medicine. Dr. Rosenblatt has served on the Advisory Committee of the American Nutraceutical Association. He helped develop and served as the Program Coordinator of the Complementary Medicine Program at Cedars-Sinai Medical Center. He is the author of many published research articles, and his best selling book The Starch Blocker Diet was published by HarperCollins. This book is now selling in the paperback edition and has been translated and published in a German-language edition.  His most recent book has been published by Balboa Press entitled, The Birth of Acupuncture in America: The White Cranes Gift (co-authored with Keith Kirts). Its available in all major book stores and on Amazon. Dr. Rosenblatt is a nationally recognized leader in the field of integrative medicine, and his major interest is the utilization and integration of complementary medicine in the Western medical clinic.  He maintains a busy clinical practice combining family practice medicine, acupuncture, and complementary modalities with offices in West Los Angeles, Van Nuys, Eagle Rock, and the Big Island of Hawaii. He is currently on staff at Saint Johns Health Center in Santa Monica.

(131) 044 - 4291

757 Westwood Plaza,Los Angeles,CA

Dr. Sherin U. Devaskar is Executive Chair of the Department of Pediatrics at UCLA. Hospital Appointments Physician-in-Chief, Mattel Children's Hospital Sherin U. Devaskar, MD is Distinguished Professor of Pediatrics, Mattel Executive Endowed Chair of the Department of Pediatrics at the David Geffen School of Medicine at UCLA. She is the Physician-in-Chief, Mattel Children's Hospital UCLA, and Assistant Vice Chancellor of Children’s Health, UCLA Health. She is also the Executive Director of the UCLA Children's Discovery and Innovation Institute (CDI). Dr. Devaskar is a highly accomplished pediatrician/neonatologist, researcher and educator. She was selected as the recipient of the 2021 John Howland Award and Medal for Highest Achievements in promoting child health as a leader, physician-scientist, mentor and clinician-educator. Dr. Devaskar's research is renowned for elucidating mechanisms and processes responsible for developmental origins of chronic childhood disorders such as obesity and diabetes with a recent emphasis on the effect of placental health on neurodevelopment. Her research is supported by National Institutes of Health (NIH). Dr. Devaskar has authored over 160 publications in peer-reviewed journals. She served as a member of the National Advisory Child Health and Human Development Council, National Institutes of Health, Chair of the NICHD-Maternal and Child Health Committee and Chair of the NIH-Human and Embryology Study Section. She was also the President of the American Pediatric Society and served on the International Pediatric Research Foundation Board. She is currently the President of the American Medical School Pediatric Department Chairs. Dr. Devaskar was elected to the Institute of Medicine (IOM) in October 2012. Dr. Devaskar has a particular interest in academic development and focuses on supporting and mentoring fellows and junior faculty interested in becoming physician-scientists, clinician-researchers or educators. Dr. Devaskar serves on multiple UCLA, national and international committees. She served as the Chair of the Scientific Program Committee for the Pediatric Academic Societies. She was a member of the Perinatal-Neonatal Subsection of the American Board of Pediatrics. Dr. Devaskar served as the Editor-in-Chief of the Pediatric Research journal. More locally, she is known to Pediatricians and Families in the Los Angeles Area, given her. passion for providing the best and safe care in a family centered manner for babies and children and has worked tirelessly to make this happen

(131) 082 - 5943

200 Medical Plaza Driveway Suite 265,Los Angeles,CA

Grace M. Aldrovandi, MD CM, is a physician-scientist and Chief of the Division of Infectious Diseases at UCLA Mattel Children’s Hospital and a Professor of Pediatrics at the David Geffen School of Medicine of the University of California, Los Angeles. Dr. Aldrovandi is a board-certified pediatric infectious diseases specialist with over 20 years experience in caring for both general pediatric infectious diseases as well as HIV infected children and their families. Dr. Aldrovandi’s research interests include pediatric HIV, the effects of breast milk on child health and infections in immunocompromised children. She has published more than 100 peer review publications in such journals as Nature, Journal of Virology, and the New England Journal of Medicine and multiple book chapters. She has been a member of multiple National Institutes of Health study sections and lectured throughout the world. She also was invited by the National Institutes of Health (NIH) to serve as a member of the AIDS Immunology and Pathogenesis Study Section of the Center for Scientific Review. As a researcher, Dr. Aldrovandi has chaired national and international studies on HIV pathogenesis within the International Maternal, Pediatric and Adolescent AIDS Clinical Trials Network (IMPAACT) and the Adolescent Trials Network (ATN). She was elected Chair of the IMPAACT Laboratory Committee, where she provides scientific leadership and quality assurance/quality control programs for all the laboratories (Virology, Immunology, Pharmacology and Genetics). Dr. Aldrovandi was recently selected to Chair the AIDS Clinical Trials Group (ACTG) Laboratory Center in addition where she performs similar duties. She is the former Chair of the Pediatric AIDS Clinical Trials Group (PACTG) Virology Committee and a member of the phenotypic and genotypic resistance working groups as well as the dried blood spot swat team. She is also a member of the Genotypic Advisory Committee of the NIAID VQA to establish a DAIDS quality assurance program for genotypic analysis of drug resistance mutations. She has considerable scientific expertise in pediatric HIV, basic HIV virology, HIV clinical assays and HIV drug resistance. Dr. Aldrovandi has been awarded the prestigious Elizabeth Glaser Scientist Award for her work on breast milk transmission of HIV-1. More recently, Dr. Aldrovandi has investigated the role of the microbiome in normal infant development, how the microbiome is perturbed by HIV-1, and how the microbiome affects HIV-1 susceptibility at mucosal sites. Her initial interest in the microbiome developed from her studies of breast milk and breast milk transmission of HIV-1. Mother’s actively excrete bacteria and special proteins, human milk oligosaccharides, thought to support the commensal bacterial, to their infants via breast milk. Certain immune cells in the infant gut do not develop until the cells receive signals from the commensal bacteria. It is this complex interplay between mother, infant and microbe that Dr. Aldrovandi is trying to understand through many of her microbiome studies. Additionally, her investigations have expanded to improve the understanding of the microbiome in HIV susceptibility and its role in human disease and treatment response. Dr. Aldrovandi received two bachelor’s degrees and her medical degree from McGill University in Montreal, Canada. She completed an internship and residency at McGill, as well as a research fellowship in pediatric infectious diseases at the University of California, Los Angeles.

(131) 082 - 5086

8635 West 3rd Street Suite 1090W,Los Angeles,CA

Dr. Aronowitz's scope of practice encompasses most areas of cosmetic and reconstructive plastic surgery with an emphasis on the use of the bodys natural adipose or fat tissues for regrowth and regeneration of body tissues damaged from surgery, radiation and age with less need for invasive muscle flap surgery and foreign implants. Dr. Aronowitz founded the University Stem Cell Center in 2009 to conduct IRB reviewed clinical adipose stem cell research not widely available yet for American patients. These highly publicized studies use the patients fat stores for breast enlargement and breast regrowth after breast cancer surgery and radiation treatment. Slow adoption of proven breast cancer surgery advances motivated Dr. Aronowitz to found the Breast Preservation Foundation (BPF), a non-profit 501c. The BPF works to promote innovative alternatives to disfiguring breast cancer surgery, such as nipple-sparing mastectomy. Charitable funds are used help advocacy groups educate women about these options and teach Oncoplastic operations to cancer surgeons in America and internationally. Many notable people and celebrities count Dr. Aronowitz as their plastic surgeon, and he is frequently the preferred choice of doctors for their families based on his reputation for natural results and skill in handling the most difficult problems. He travels widely to speak on Advances in Cell Based Surgery Therapies, Oncoplastic Surgery and present his latest clinical research findings. Dr. Aronowitz is recognized in numerous media appearances and print as an expert spokesperson on issues related to emerging cellular therapies, cosmetic and oncoplastic surgery. Dr. Aronowitz private practice is based at the highly ranked Cedars-Sinai Medical Center where he served as for many years as Chief, Division Plastic Surgery, the Medical Executive Committee and other leadership roles. He is deeply committed to improving patient care through active involvement in lay advocacy groups and professional societies. He serves on Board of Directors of the American Society of Breast Disease, Faculty for the ASBD School of Oncoplastic Surgery, expert for the California Board of Medical Quality Assurance and is Assistant Clinical Professor at USC Keck School of Medicine. The doctor holds memberships in the leading professional societies, such as the ASPS, AAPS, and, Soc Bariatric PS, LASPS. On a personal note, Dr. Aronowitz recently celebrated over 30 years of marriage and is the proud parent of four very nice young people. He is a regular on the local tennis court but not much of a threat. Dr. Aronowitz and his wife are involved in local schools, enjoy traveling and the fine art community.

(131) 059 - 6399

100 Medical Plaza Driveway Suite 525,Los Angeles,CA

Benjamin J. Ansell, MD, received a dual undergraduate degree with distinction in Biology and as a College Scholar in Music from Cornell University, followed by his Doctor of Medicine from the University of California Los Angeles (UCLA) School of Medicine. He subsequently performed an internship and residency in Internal Medicine at the UCLA Medical Center. Dr. Ansell currently serves as Professor at the David Geffen School of Medicine at UCLA in the Divisions of General Internal Medicine and Cardiology. He is also Director of the Comprehensive Health Program, Co-Director of Cholesterol, Hypertension, and Atherosclerosis Management Program (CHAMP) and the Medical Hospitality Program at UCLA. Dr. Ansell is a member of the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology, and certified by the American Boards of Internal Medicine and Clinical Lipidology. He has been elected as a Fellow of the American College of Physicians, the American College of Cardiology, and the National Lipid Association. He is a member of the Board of the National Lipid Association, past member of the Board of the Pacific Lipid Association, past President of the Executive Board of the UCLA Department of Medicine Professional Group, and current member of the Managed Care Utilization Review Committee of the UCLA Medical Group. Dr. Ansell is the founder and director of the Cardiovascular Discovery Fund, which supports promising novel developments in heart disease and related conditions. He has also served as a Director of the Ashford Hospitality Trust (NYSE: AHT) since 2009. Listed among Castle-Connolly's "America's Top Doctors" and chosen by Town & Country magazine as one of the "Best Physicians in America," Dr. Ansell has a range of research experience relating to cholesterol treatment strategies in preventing and managing cardiovascular diseases. He has been principal investigator of the hs-CRP and HDL Effects of Statins Trial (CHEST), the Statins/HDL Increased Function Trial (SHIFT), and the Statin Anti-Rheumatic Activity (SARA) Trial. He is on the review boards of the Journal of the American College of Cardiology, The American Journal of Cardiology, and the Journal of General Internal Medicine, among others. He has delivered approximately two hundred invited lectures, as well as published 40 peer-reviewed papers in the Journal of the American Medical Association, Journal of the American College of Cardiology, Circulation, Archives of Internal Medicine, and the American Journal of Cardiology, among others. His publications have focused on HDL (high-density lipoprotein) and inflammation, cholesterol management, stroke reduction, cardiovascular risk reduction in women, and national cholesterol guidelines. He has also been featured by The New York Times, The Los Angeles Times, National Public Radio, Glamour Magazine, ABC World News Tonight, MSNBC, and Dateline NBC.

(131) 079 - 4488